...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The Canadian Journal of Neurological Sciences: le Journal Canadien des Sciences Neurologiques >Assessment of behavioural and psychological symptoms associated with dementia.
【24h】

Assessment of behavioural and psychological symptoms associated with dementia.

机译：评估与痴呆症相关的行为和心理症状。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Neuropsychiatric symptoms (mood, psychotic, and behavioural) are very common in dementia and do not necessarily correlate well with other measures of cognition. However, these symptoms are of great importance, as they are a major source of excess disability, patient distress and caregiver burden and have great impact on the level of care required, and the associated costs. This paper is a review of the most useful outcome measures for behaviour and mood symptoms. Investigators who require a comprehensive instrument to measure neuropsychiatric symptoms in studies of patients with dementia should consider using the Neuropsychiatric Inventory (NPI), the Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD-BRSD) or, possibly, the Behavioral Pathology in Alzheimer's Disease Scale (BEHAVE-AD). The Cornell Scale for Depression in Dementia and the Dementia Mood Assessment Scale (DMAS) are recommended for evaluating depressive symptoms and the Cohen-Mansfield Agitation Inventory (CMAI) is very useful for evaluating the full range of agitation symptoms.
机译：神经精神症状（情绪，精神病和行为）在痴呆症中很常见，不一定与其他认知指标相关。但是，这些症状非常重要，因为它们是造成严重残疾，患者痛苦和护理人员负担的主要来源，并且对所需的护理水平和相关费用产生重大影响。本文是对行为和情绪症状最有用的结局指标的综述。需要在痴呆症患者研究中测量神经精神症状的综合仪器的研究人员应考虑使用神经精神病学调查表（NPI），财团对痴呆的行为评分量表来建立阿尔茨海默氏病注册系统（CERAD-BRSD），或者可能，阿尔茨海默氏病量表的行为病理学（BEHAVE-AD）。建议使用康奈尔抑郁症抑郁量表和痴呆情绪评估量表（DMAS）来评估抑郁症状，而科恩-曼斯菲尔德烦躁量表（CMAI）对于评估各种躁动症状非常有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号